Organization: UNC / UNC Health

  We study outcomes related to valvular heart disease. Specifically, we examine the role of newer transcatheter therapies on the clinical outcomes of patients with heart valve disease. Using a number of local and national databases, we explore the epidemiological impact of minimally invasive heart valve disease treatment on outcomes...

  The microbiome is emerging as a modifiable driver of drug responses (efficacy and toxicity). My lab is advancing the field of pharmacomicrobiomics, or, how functions of the gut microbiota transform medications via what we term “Phase IV” metabolism, thus contributing to inter-individual variability in drug response. We use new...

  Broadly, I seek to interrogate the intersection of pediatric endocrine clinical care and sociocultural understandings and experiences of sex and gender to identify potential harms and areas for improvement in current clinical care practices. My work is transdisciplinary and combines research approaches from clinical medicine, bioethics, and social medicine....

  I lead a wide range of research spanning image acquisition, reconstruction, quality control, harmonization, processing, and analysis with applications in neuroscience, disease diagnosis, and surgical planning.

  My research interests address host defense mechanisms in the lungs, particularly the inflammatory and innate immune processes that are important in the pathogenesis and course of bacterial pneumonia and acute lung injury/acute respiratory distress syndrome, diseases which affect both the pediatric and the adult population. Basic and translational studies...

  My research focuses on the development of advanced biomaterials and medical devices using cutting-edge additive manufacturing and laser-based processing techniques. My team is a pioneer in the use of two-photon polymerization for fabricating microscale and nanoscale medical devices, including tissue engineering scaffolds, microneedles, and complex three-dimensional medically relevant microstructures....

  I am a surgical oncologist researching improving outcomes after complex hepatobiliary surgery. I aim to develop preoperative behavioral interventions that will improve both surgical outcomes and overall survival for patients with fatty liver disease.

Dr. Dellon is an academic gastroenterologist with formal research training in epidemiology, clinical and translational research, and clinical trial design. He leads multidisciplinary research teams in eosinophilic esophagitis (EoE) and eosinophilic GI diseases (EGIDs). His research focuses on optimizing the diagnosis, characterizing the epidemiology, studying the pathogenesis, and refining the...

  My research explores how experiences early in life, even before and shortly after birth, can shape kidney and heart health as children grow. I focus on understanding which infants and children are at higher risk for kidney problems and how we can identify that risk earlier. My long-term goal...

Dr. Stephens is primarily interested in early cognitive development, specifically attention and executive function, and how those skills are related to later cognition. She is also interested in the neurobiological underpinnings of these behaviors, as well as typical and atypical trajectories of brain development. She has worked with UNC’s NeuroImage...

  During infection individual cells of a bacterial pathogen can co-occur in distinct physiological states. Such phenotypic heterogeneity has been recently reported in landmark virulence processes including expression of toxin genes, sporulation, genetic exchange, cell-attachment, and resistance and persistence to antibiotics and can provide community benefit to the pathogen. The...

  I’m very interested in understanding the structural and behavioral factors that influence the spread of HIV among men who have sex with men (MSM) – especially young MSM of color in the Southeastern US. My research in this area is split between studying HIV testing and prevention behaviors and...